Clinical Trials on Meningitis, Bacterial

Total 17934 results

Royal Brisbane and Women's Hospital
The University of Queensland

Completed

An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT (CT-PK)

Gram-Negative Bacterial Infections

Australia
Kaplan Medical Center

Unknown

Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome

Infection, Bacterial | Pacemaker Complication
Pfizer

Completed

Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate

Bacterial Infection

India
Xuanwu Hospital, Beijing

Not yet recruiting

Establishment of Prevention and Control System of Central Nervous System Infection

Encephalitis | Meningitis | Central Nervous System (CNS) Infection

China
Ayşe AKBIYIK

Completed

Oropharyngeal Aspiration to Reduce Ventilator-Related Pneumonia

Ventilator-associated Bacterial Pneumonia
First Affiliated Hospital of Zhejiang University

Recruiting

Antibiotics Resistance Gene in Healthcare Workers (ARGH)

Multidrug Resistant Bacterial Infection

China
Mical Paul
European Commission

Completed

Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem

Gram-Negative Bacterial Infections

Israel, Greece, Italy
Guy's and St Thomas' NHS Foundation Trust

Unknown

Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread

Gram-Negative Bacterial Infections

United Kingdom
Vedic Lifesciences Pvt. Ltd.

Recruiting

A Pilot Study to Evaluate the Efficacy and Safety of Lactobacillus Species Suppositories on Vaginal Health and pH

Bacterial Vaginosis

India
Perfect Care Distribution
MDX Research

Completed

Real-world Performance and Safety of Cerviron® in the Treatment of Vaginitis

Vaginitis | Bacterial Vaginosis

Romania
Laboratorios Sophia S.A de C.V.

Terminated

Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. (PRO-157)

Conjunctivitis, Bacterial

Mexico
Osel, Inc.
University of California, San Francisco

Completed

Safety Study of Lactobacillus Administered Vaginally to Healthy Women

Bacterial Vaginosis

United States
Texas Tech University Health Sciences Center, El...
The City of El Paso Department of Public Health

Completed

El Paso Public Health Biorepository (EPB)

Oral Disease | Bacterial Disease

United States
Danisco
Community Pharmacology Services Ltd

Completed

PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?" (PreFem)

Bacterial Vaginosis

United Kingdom
Lupin Research Inc

Completed

Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV

Bacterial Vaginoses

United States
GlaxoSmithKline

Completed

Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age

Neisseria Meningitidis | Haemophilus Influenzae Type b

United States
GlaxoSmithKline

Completed

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Neisseria Meningitidis | Haemophilus Influenzae Type b

Australia
GlaxoSmithKline

Completed

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine

Neisseria Meningitidis | Haemophilus Influenzae Type b

United States
GlaxoSmithKline

Completed

Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB

Neisseria Meningitidis | Haemophilus Influenzae Type b

United States
GlaxoSmithKline

Completed

Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain
GlaxoSmithKline

Completed

Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine

Neisseria Meningitidis | Haemophilus Influenzae Type b

Finland, Italy
GlaxoSmithKline

Completed

Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine

Neisseria Meningitidis | Haemophilus Influenzae Type b

Poland, United Kingdom
GlaxoSmithKline

Completed

Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Unknown

The Efficacy and Safety of Daptomycin in the Treatment of Gram-positive Bacterial Infection.

Antibiotic

China
University Hospital, Clermont-Ferrand

Unknown

Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX) (MAX-AMOX)

Infection, Bacterial

France
Pfizer

Completed

Post Marketing Surveillance Study on Linezolid (A5951090)

Gram-Positive Bacterial Infections
National Taiwan University Hospital

Unknown

Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients

Gram-Negative Bacterial Infections

Taiwan
GlaxoSmithKline

Completed

Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

Infections, Bacterial

United States
Melinta Therapeutics, Inc.

Completed

Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia (DEFINE-CABP)

Community Acquired Bacterial Pneumonia

United States, Argentina, Bulgaria, Colombia, Dominican Republic, Georgia, Germany, Hungary, Latvia, Peru, Poland, Romania, Russian Federation, Serbia, Slovenia, South Africa, Spain, Ukraine
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-ORAL)

Community-acquired Bacterial Pneumonia

Spain, United States, Hungary, Canada, Estonia, Russian Federation, Argentina, Bulgaria, Czech Republic, Dominican Republic, Ecuador, Germany, Latvia, Poland, Puerto Rico, Romania, South Africa
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-IV)

Community-acquired Bacterial Pneumonia

Spain, United States, Philippines, Taiwan, Canada, Germany, Poland, Russian Federation, Argentina, Bulgaria, South Africa, Slovenia, Serbia, Colombia, Hungary, Netherlands, Slovakia, Ukraine, Peru, Latvia, Guatemala, Romania, Chile, G... and more
University Ghent
Agentschap voor Innovatie door Wetenschap en Technologie

Completed

Safety and Efficacy of a Vaginally Administered Probiotic Lactobacilli Delivery System.

Bacterial Vaginosis

Belgium
University of Washington
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity

Bacterial Vaginosis

United States
The University of Texas Medical Branch, Galveston

Completed

Role of Oral Lactobacilli on Vaginal Flora of Pregnant Women

Bacterial Vaginosis
Ohio State University

Completed

Vitamin D and Sexual Health (DASH)

Bacterial Vaginosis

United States
Zai Lab (Hong Kong), Ltd.

Recruiting

A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP (public)

Community-acquired Bacterial Pneumonia

United States
Melinta Therapeutics, Inc.
Biomedical Advanced Research and Development Authority

Terminated

Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia

Community-acquired Bacterial Pneumonia

Spain, United States, Philippines, Hungary, United Kingdom, Bulgaria
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Community-Acquired Bacterial Pneumonia

United States, Canada
Fundación Pública Andaluza para la gestión de la...
European Commission

Completed

Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB) (MagicBullet)

Ventilator-associated Bacterial Pneumonia

Spain, Italy, Greece
Albany Medical College
Forest Laboratories; Albany College of Pharmacy and Health Sciences

Completed

Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia (CAP)

Community Acquired Bacterial Pneumonia

United States
Mount Sinai Hospital, Canada
Unity Health Toronto

Completed

Probiotic Therapy for the Reversal of Bacterial Vaginosis in Pregnancy (ProVIP)

Pregnant Women Who Test Positive for Bacterial Vaginosis

Canada
Melinta Therapeutics, LLC

Recruiting

Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections

Gram Positive Bacterial Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Bacterial Vaginosis Home Screening to Prevent STDs

Bacterial Vaginosis

United States
Gage Development Company, LLC
Health Decisions

Completed

Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis

Bacterial Vaginosis

United States
Starpharma Pty Ltd

Completed

A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis

Bacterial Vaginosis
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis

Bacterial Vaginosis

United States
University of Alabama at Birmingham
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Treatment of Bacterial Vaginosis (BV) With Tinidazole

Bacterial Vaginosis

United States
Mission Pharmacal

Completed

Treatment of Bacterial Vaginosis With Oral Tinidazole

Bacterial Vaginosis

United States
University of British Columbia

Completed

BASIC (Boric Acid, Alternate Solution for Intravaginal Colonization) Study

Bacterial Vaginosis

Canada
Skaraborg Hospital
Karolinska University Hospital

Completed

Treatment of Bacterial Vaginosis Combined With Human Lactobacilli

Bacterial Vaginosis

Norway

Clinical Trials on Meningitis, Bacterial

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations